VivoSeq
Other

Hyaluronic Acid

0

Pipeline Programs

14

Active Trials

0

Companies Involved

Hyaluronic Acid is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

69

clinical trials

Completed38 · 55%
Unknown status17 · 25%
Recruiting7 · 10%
Not yet recruiting7 · 10%

Trial Activity

69 trials

Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study
Not yet recruiting·NNYU Langone Health·N/A·NCT07038070·196 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)